Integrated safety analysis of rolapitant with coadministered drugs from phase II/III trials: an assessment of CYP2D6 or BCRP inhibition by rolapitant
| Autor: | Barbour, S. *, Smit, T., Wang, X., Powers, D., Arora, S., Kansra, V., Aapro, M., Herrstedt, J. |
|---|---|
| Zdroj: | In Annals of Oncology June 2017 28(6):1268-1273 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|